Hao Xu

6.8k total citations · 2 hit papers
170 papers, 4.5k citations indexed

About

Hao Xu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Hao Xu has authored 170 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 31 papers in Surgery and 28 papers in Cancer Research. Recurrent topics in Hao Xu's work include Oral Health Pathology and Treatment (24 papers), Head and Neck Cancer Studies (14 papers) and RNA modifications and cancer (12 papers). Hao Xu is often cited by papers focused on Oral Health Pathology and Treatment (24 papers), Head and Neck Cancer Studies (14 papers) and RNA modifications and cancer (12 papers). Hao Xu collaborates with scholars based in China, United States and Sweden. Hao Xu's co-authors include Qianming Chen, Xin Zeng, Hongxia Dan, Jiakuan Peng, J. S. Deng, Taiwen Li, Liang Zhong, Lu Jiang, Weijiu Liang and Dasheng Lu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Renewable and Sustainable Energy Reviews.

In The Last Decade

Hao Xu

152 papers receiving 4.4k citations

Hit Papers

High expression of ACE2 receptor of 2019-nCoV on the epit... 2020 2026 2022 2024 2020 2024 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Xu China 29 1.3k 823 563 461 402 170 4.5k
Eliete Neves Silva Guerra Brazil 37 205 0.2× 888 1.1× 166 0.3× 792 1.7× 489 1.2× 159 4.1k
Andrea Ballini Italy 41 359 0.3× 1.1k 1.4× 130 0.2× 701 1.5× 510 1.3× 206 4.3k
Luiz Fernando Ferraz da Silva Brazil 31 670 0.5× 331 0.4× 249 0.4× 82 0.2× 441 1.1× 150 3.6k
Marisa Dolhnikoff Brazil 45 821 0.6× 536 0.7× 269 0.5× 51 0.1× 599 1.5× 167 5.8k
Shankargouda Patil India 32 152 0.1× 1.6k 1.9× 85 0.2× 828 1.8× 374 0.9× 388 5.5k
Srinivas M. Susarla United States 38 159 0.1× 2.1k 2.5× 537 1.0× 195 0.4× 1.5k 3.7× 232 8.7k
Pía López‐Jornet Spain 37 128 0.1× 383 0.5× 300 0.5× 1.6k 3.6× 631 1.6× 239 4.7k
Anne Marie Lynge Pedersen Denmark 32 166 0.1× 677 0.8× 169 0.3× 2.3k 5.0× 649 1.6× 109 5.3k
Yan Ren China 30 140 0.1× 361 0.4× 183 0.3× 679 1.5× 216 0.5× 129 3.3k
Ali Bijani Iran 27 202 0.2× 324 0.4× 121 0.2× 347 0.8× 371 0.9× 381 3.2k

Countries citing papers authored by Hao Xu

Since Specialization
Citations

This map shows the geographic impact of Hao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Xu more than expected).

Fields of papers citing papers by Hao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Xu. The network helps show where Hao Xu may publish in the future.

Co-authorship network of co-authors of Hao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Xu. A scholar is included among the top collaborators of Hao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Xu. Hao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Hao, Hao Wang, Shuwan Yu, et al.. (2025). Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma. European Radiology. 35(7). 4121–4131. 2 indexed citations
2.
Xu, Hao, Sun‐Zhe Xie, Yinghan Su, et al.. (2025). Comparison of 11C‐Acetate and 18FFDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma. Cancer Science. 116(4). 990–1003.
3.
Ding, Zihan, et al.. (2024). Developing a machine learning model for accurate nucleoside hydrogels prediction based on descriptors. Nature Communications. 15(1). 2603–2603. 28 indexed citations
4.
Song, Yansong, Fan Tang, Jiaxin Liu, et al.. (2024). A complete course of photodynamic therapy reduced the risk of malignant transformation of oral leukoplakia. Photodiagnosis and Photodynamic Therapy. 49. 104338–104338.
5.
Yang, Dan, Jiaxin Liu, Yansong Song, et al.. (2023). MRTF‐A / SRF signaling suppresses invasion of oral squamous cell carcinoma. Oral Diseases. 30(4). 1919–1934. 1 indexed citations
6.
Liu, Jiaxin, Hao Xu, Guoyao Tang, et al.. (2023). A multi‐center cross‐sectional study of 1495 Chinese oral lichen planus patients. Oral Diseases. 30(5). 3155–3164. 4 indexed citations
7.
Lan, Ting, Ying Li, Yue Wang, et al.. (2023). Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway. Cell Death and Disease. 14(1). 39–39. 15 indexed citations
8.
Zhang, Jie, Dan Ma, Zihao Zhang, et al.. (2023). Association between healthy eating index-2015 and abdominal aortic calcification among US Adults. Frontiers in Nutrition. 9. 1027136–1027136. 7 indexed citations
9.
Chen, Dawei, Yiming Xu, Ying Wang, et al.. (2022). Prevalence of oral lichen planus in patients with diabetes mellitus: A cross‐sectional study. Oral Diseases. 30(2). 528–536. 8 indexed citations
10.
Zhou, Yu, Jiakuan Peng, Qianhui Shang, et al.. (2022). The interleukin‐6 family in tissues is closely related to the clinical outcomes of oral lichen planus. Journal of Oral Pathology and Medicine. 52(2). 161–168. 1 indexed citations
11.
Shang, Qianhui, Jiakuan Peng, Yuchen Jiang, et al.. (2022). SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p‐EMT. Oral Diseases. 29(8). 3232–3242. 4 indexed citations
12.
Wu, Ying, Hao Xu, Yufeng Wang, et al.. (2022). An improved scoring system for monitoring oral lichen planus: A preliminary clinical study. Oral Diseases. 29(8). 3337–3345. 10 indexed citations
13.
Chen, Qian, Yujie Shi, Hao Xu, et al.. (2021). Activation of EGFR‐Aurora A induces loss of primary cilia in oral squamous cell carcinoma. Oral Diseases. 28(3). 621–630. 11 indexed citations
14.
Li, Long, et al.. (2020). Anxiety and oral lichen planus. Oral Diseases. 27(3). 506–514. 21 indexed citations
15.
Xu, Hao, et al.. (2020). No evidence for vertical transmission of SARS-CoV-2 in two neonates with mothers infected in the second trimester. Infectious Diseases. 52(12). 913–916. 8 indexed citations
16.
Lin, Weimin, Hao Xu, Yunshu Wu, Jun Wang, & Quan Yuan. (2019). In silico genome‐wide identification of m6A‐associated SNPs as potential functional variants for periodontitis. Journal of Cellular Physiology. 235(2). 900–908. 31 indexed citations
17.
Xu, Hao, Yao Yuan, Peng Deng, et al.. (2017). Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study. Scientific Reports. 7(1). 7522–7522. 29 indexed citations
18.
Fu, Ru‐Huei, Kefei Dou, Jie Yang, et al.. (2016). [Age-related differences in the clinical symptoms and triggering factors among Chinese patients with acute myocardial infarction].. PubMed. 44(4). 298–302. 1 indexed citations
19.
Chen, Yen‐Liang, Hao Xu, Hongping Dong, et al.. (2015). Synergistic Suppression of Dengue Virus Replication Using a Combination of Nucleoside Analogs and Nucleoside Synthesis Inhibitors. Antimicrobial Agents and Chemotherapy. 59(4). 2086–2093. 52 indexed citations
20.
Tang, Hong, Yong Li, Pingping Zhang, et al.. (2015). [Surveillance for diarrheagenic Escherichia coli in Shanghai, 2012-2013].. PubMed. 36(11). 1263–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026